» Articles » PMID: 37452094

Development and Validation of a Nomogram Model for Predicting Chronic Kidney Disease After Liver Transplantation: a Multi-center Retrospective Study

Overview
Journal Sci Rep
Specialty Science
Date 2023 Jul 14
PMID 37452094
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic kidney disease (CKD) is a frequent complication after liver transplantation (LT) and associated with poor prognosis. In this study, we retrospectively analyzed 515 adult patients who underwent LT in our center. They were randomly divided into a training set (n = 360) and an internal test set (n = 155). Another 118 recipients in other centers served as external validation set. Univariate and multivariate COX regression analysis were used to determine risk factors. A nomogram model was developed to predict post-LT CKD. The incidence of post-LT CKD in our center was 16.9% (87/515) during a median follow-up time of 22.73 months. The overall survival of recipients with severe CKD (stage IV and V) were significantly lower than those with non or mild CKD (stage III) (p = 0.0015). A nomogram model was established based on recipient's age, anhepatic phase, estimated glomerular filtration rate and triglyceride levels at 30 days after LT. The calibration curves for post-LT CKD prediction in the nomogram were consistent with the actual observation in both the internal and external validation set. In conclusion, severe post-LT CKD resulted in a significantly reduced survival in liver recipient. The newly established nomogram model had good predictive ability for post-LT CKD.

References
1.
Zou Y, Han H, Ruan S, Jian Z, Jin L, Zhang Y . Development of a Nomogram to Predict Disease-Specific Survival for Patients After Resection of a Non-Metastatic Adenocarcinoma of the Pancreatic Body and Tail. Front Oncol. 2020; 10:526602. PMC: 7658586. DOI: 10.3389/fonc.2020.526602. View

2.
Fellstrom B, Jardine A, Schmieder R, Holdaas H, Bannister K, Beutler J . Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med. 2009; 360(14):1395-407. DOI: 10.1056/NEJMoa0810177. View

3.
Sharma P, Welch K, Eikstadt R, Marrero J, Fontana R, Lok A . Renal outcomes after liver transplantation in the model for end-stage liver disease era. Liver Transpl. 2009; 15(9):1142-8. DOI: 10.1002/lt.21821. View

4.
Staatz C, Tett S . Pharmacokinetic considerations relating to tacrolimus dosing in the elderly. Drugs Aging. 2005; 22(7):541-57. DOI: 10.2165/00002512-200522070-00001. View

5.
Kosmacheva E, Babich A . [Lipid spectrum and function of kidneys before and after liver transplantation]. Kardiologiia. 2019; 59(6S):17-23. DOI: 10.18087/cardio.2611. View